Biofrontera (BFRI) Invested Capital (2021 - 2024)

Biofrontera (BFRI) posted quarterly Invested Capital of $296000.0 for Q2 2024, down 87.43% quarter-over-quarter from $2.4 million in Q1 2024.

Biofrontera (BFRI) Invested Capital (2021 - 2024) Analysis & Trends

Biofrontera's Invested Capital history runs 4 years deep, the most recent figure standing at $296000.0 for Q2 2024.

In Q2 2024, Invested Capital changed N/A year-over-year to $296000.0; the TTM figure through Mar 2025 stood at $296000.0 (down 96.28% YoY), while the FY2023 annual figure was $3.9 million, down 43.76% from the prior year.
Invested Capital for Q2 2024 stood at $296000.0, down from $2.4 million in the prior quarter.
The five-year high for Invested Capital was $7.0 million in Q1 2023, with the low at $296000.0 in Q2 2024.
The 4-year median for Invested Capital is $3.2 million (2021), against an average of $3.6 million.
The sharpest annual moves came in 2022 and 2024: Invested Capital surged 114.13% in 2022, then slumped 66.51% in 2024.
Biofrontera's Invested Capital stood at $3.2 million in 2021, then surged by 114.13% to $6.9 million in 2022, then slumped by 43.76% to $3.9 million in 2023, then slumped by 92.42% to $296000.0 in 2024.
Business Quant data shows BFRI's Invested Capital at $296000.0 in Q2 2024, $2.4 million in Q1 2024, and $3.9 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	9.90 Bn
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	4.50 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	3.74 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	1.74 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	73.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	630.00 Mn
10	Biofrontera	19.06 Mn	14.35 Mn	9.59 Mn	-

Download Data